Paul Hudson, Sanofi CEO (Jeremy Paoloni/Abaca/Sipa USA(Sipa via AP Images))
March 4, 2024 11:32 AM ESTUpdated 11:53 AM
Pharma

Q&A: Sanofi’s CEO on the con­sumer di­vesti­ture, a fu­ture in weight loss, an­titrust and AI’s se­cre­cy wave

Drew Armstrong

Executive Editor

Last week, End­points News ex­ec­u­tive ed­i­tor Drew Arm­strong sat down with Sanofi CEO Paul Hud­son in Boston at the com­pa­ny’s ex­pan­sive com­plex. They spoke about …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times